Medline Inc.

Medline Inc. (MDLN) priced its initial public offering on Dec 18, 2025 at $29.00 per share, within its $26.00–$30.00 range, raising $6.26B, and listed on Nasdaq Global Select. At the IPO price its market capitalization was about $38.1B. Goldman Sachs was lead-left underwriter, joined by Morgan Stanley, BofA Securities and J.P. Morgan and others.

Medline Inc. provides medical-surgical products and supply chain solutions to hospitals, surgery centers, physician offices and post-acute facilities. It offers roughly 335,000 products, including surgical kits, gloves, wound care and lab consumables, through its Medline Brand and Supply Chain Solutions segments.

Status

IPO

Ticker

MDLN

Exchange

Nasdaq Global Select

Priced

Dec 18, 2025

IPO price

$29.00

Price range

$26.00–$30.00

Raised

$6.26B

Market cap at IPO price

$38.1B

First filed

Oct 28, 2025

Underwriters

Goldman Sachs, Morgan Stanley, BofA Securities, J.P. Morgan, Barclays, Citigroup, Deutsche Bank, Jefferies, UBS, Evercore ISI, BMO Capital Markets and RBC Capital Markets

Sector

Healthcare

Country / state

IL

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.